- $816.97m
- $1.11bn
- $568.09m
Brief: Bioventus Agrees To Nationwide Contract With Aetna™ Medicare Advantage Plans For Durolane® For Knee Osteoarthritis
U.S. RESEARCH ROUNDUP-Air Products and Chemicals, Assurant, Celanese
Brief: Bioventus Reports Third Quarter Financial Results Raises Full Year 2023 Financial Guidance
Brief: Bioventus Q3 Adjusted EPS USD 0.05
Bioventus Inc expected to post a loss of 2 cents a share - Earnings Preview
Bioventus Inc reports results for the quarter ended in June - Earnings Summary
Brief: Bioventus Reports Second Quarter Financial Results Introduces Full Year 2023 Guidance
Bioventus Inc expected to post breakeven results a share - Earnings Preview
Bioventus set for five-day winning streak, says completes divestiture
Brief: Bioventus Completes Divestiture Of Its Wound Business
Bioventus falls on wider Q1 loss
Bioventus Inc reports results for the quarter ended in March - Earnings Summary
Brief: Bioventus Reports First Quarter Financial Results
Brief: Bioventus Q1 sales USD 119.1 million
Bioventus Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Bioventus Announces Divestiture Of Wound Business
Bioventus Inc expected to post a loss of 15 cents a share - Earnings Preview
Bioventus Inc expected to post a loss of 15 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Allete, Gilead Sciences, Arcutis